![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Gibbs, Peter; Heinemann, Volker; Sharma, Navesh K.; Taieb, Julien; Ricke, Jens; Peeters, Marc; Findlay, Michael; Robinson, Bridget; Jackson, Christopher; Strickland, Andrew; Gebski, Val; Buskirk, Mark van; Zhao, Huaqing und Hazel, Guy van
(2018):
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.
In: Clinical Colorectal Cancer, Bd. 17, Nr. 4, E617-E629
Wasan, Harpreet S.; Gibbs, Peter; Sharma, Navesh K.; Taieb, Julien; Heinemann, Volker; Ricke, Jens; Peeters, Marc; Findlay, Michael; Weaver, Andrew; Mills, Jamie; Wilson, Charles; Adams, Richard; Francis, Anne; Moschandreas, Joanna; Virdee, Pradeep S.; Dutton, Peter; Love, Sharon; Gebski, Val; Gray, Alastair; Hazel, Guy van und Sharma, Ricky A.
(2017):
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
In: Lancet Oncology, Bd. 18, Nr. 9: S. 1159-1171
Wasan, Harpreet; Hazel, Guy van; Heinemann, Volker 
ORCID: https://orcid.org/0000-0002-1349-3321; Sharma, Navesh; Taieb, Julien; Ricke, Jens; Peeters, Marc; Findlay, Michael; Pradeep, Virdee S.; Sharon, Love; Moschandreas, Joanna; Dutton, Peter; Gebski, Val; Gray, Alastair; Price, Dave; Bower, Geoff; Montazeri, Amir; Swinson, Daniel; Brown, Ewan; Wilson, Gregory; Lowndes, Sarah; Ricky A., Sharma und Gibbs, Peter
(2017):
Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer.
In: Annals of Oncology, Bd. 28
ORCID: https://orcid.org/0000-0002-1349-3321; Sharma, Navesh; Taieb, Julien; Ricke, Jens; Peeters, Marc; Findlay, Michael; Pradeep, Virdee S.; Sharon, Love; Moschandreas, Joanna; Dutton, Peter; Gebski, Val; Gray, Alastair; Price, Dave; Bower, Geoff; Montazeri, Amir; Swinson, Daniel; Brown, Ewan; Wilson, Gregory; Lowndes, Sarah; Ricky A., Sharma und Gibbs, Peter
(2017):
Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer.
In: Annals of Oncology, Bd. 28
Hazel, Guy A. van; Heinemann, Volker; Sharma, Navesh K.; Findlay, Michael P. N.; Ricke, Jens; Peeters, Marc; Perez, David; Robinson, Bridget A.; Strickland, Andrew H.; Ferguson, Tom; Rodríguez, Javier; Kröning, Hendrik; Wolf, Ido; Ganju, Vinod; Walpole, Euan; Boucher, Eveline; Tichler, Thomas; Shacham-Shmueli, Einat; Powell, Alex; Eliadis, Paul; Isaacs, Richard; Price, David; Moeslein, Fred; Taieb, Julien; Bower, Geoff; Gebski, Val; Buskirk, Mark van; Cade, David N.; Thurston, Kenneth und Gibbs, Peter
(2016):
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
In: Journal of Clinical Oncology, Bd. 34, Nr. 15: S. 1723-1731
Gibbs, Peter; Heinemann, Volker; Sharma, Navesh K.; Findlay, Michael P. N.; Ricke, Jens; Peeters, Marc; Perez, David; Robinson, Bridget Anne; Strickland, Andrew; Ferguson, Tom; Rodriguez, Javier; Kroening, Hendrik; Wolf, Ido; Ganju, Vinod; Walpole, Euan Thomas; Boucher, Eveline; Tichler, Thomas E.; Gebski, Val; Buskirk, Mark van und Hazel, Guy A. van
(2016):
SIRFLOX: Differences in site of first progression between mFOLFOX6 +/- bevacizumab (bev) versus mFOLFOX6 +/- bev plus selective internal radiation therapy (SIRT) in first-line patients (pts) with metastatic colorectal cancer (mCRC).
In: Journal of Clinical Oncology, Bd. 34, Nr. 4